Research progress in the treatment of disc degeneration by bone marrow mesenchymal stem cells and their exocrine
10.11855/j.issn.0577-7402.2020.08.13
- VernacularTitle: 骨髓间充质干细胞及其外泌体治疗椎间盘退变的研究进展
- Author:
Xiao-Bo ZHANG
1
Author Information
1. Department of Orthopedics, Second Hospital of Lanzhou University
- Publication Type:Journal Article
- Keywords:
Bone marrow mesenchymal stem cells;
Exosomes;
Intervertebral disc degeneration
- From:
Medical Journal of Chinese People's Liberation Army
2020;45(8):862-868
- CountryChina
- Language:Chinese
-
Abstract:
Bone marrow mesenchymal stem cells (BMSCs) are multi-directional cells with self-renewal and differentiation into multiple types of cells, which play an important role in tissue healing and regenerative medicine. BMSCs can repair intervertebral disc degeneration (IDD) by promoting cell proliferation and expressing extracellular matrix components similar to intervertebral disc type Ⅱ collagen, proteoglycan, etc., and be expected to delay or even reverse the IDD from etiological level, but certain limitations existed. Recent studies have found that exosomes secreted by BMSCs can inhibit the apoptosis of nucleus pulposus cells through intercellular communication and slow down the occurrence of IDD. It possesses greater therapeutic advantage and is a new breakthrough in the treatment of IDD. In present paper, the latest research results have been elaborated of BMSCs and their secreted exosomes in IDD, in order to be better applied to clinical treatment.